Author: Customer Service

SmartCentres Declares Distribution for October 2026

Written by Customer Service on October 16, 2026. Posted in Dividend Reports And Estimates.

TORONTO, Oct. 16, 2026 (GLOBE NEWSWIRE) — SmartCentres Real Estate Investment Trust (“SmartCentres”) (TSX: SRU.UN) announced today that the trustees of SmartCentres have declared a distribution for the month of October 2026 of $0.15417 per unit, representing $1.85 per unit on an annualized basis. The distribution will be payable on November 16, 2026 to unitholders of record as at October 30, 2026. About SmartCentres SmartCentres is one of Canada’s largest fully integrated REITs, with a best-in-class and growing mixed-use portfolio featuring 201 strategically located properties in communities across the country. SmartCentres has approximately $12.1 billion in assets consisting of income producing value-oriented retail, purpose-built rental, first-class office and self-storage properties. SmartCentres owns 35.5 million square feet...

NeOnc’s Boldest Test Yet: Child’s Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone

Written by Customer Service on October 16, 2026. Posted in Public Companies.

Why Abu Dhabi Strategy and New Banking Director Signal Bigger Global Ambition DENVER, Oct. 16, 2026 (GLOBE NEWSWIRE) — (247marketnews.com) — NeOnc Technologies Holdings (NASDAQ: NTHI) delivered a deeply human clinical update that brings its investigational brain-cancer technology, expanding Abu Dhabi presence and high-profile banking appointment into sharper focus. The company reported that a critically ill three-year-old boy with an aggressive brain tumor is breathing independently without ventilator support and beginning to move his legs after receiving investigational intranasal NEO100 through NeOnc’s Compassionate Care program. The treatment is being administered outside the company’s pediatric clinical trial, following coordination with the child’s physicians and the Department of Health – Abu Dhabi. While a single compassionate-use...

Fabric.AI to Participate in Live YouTube “Ask Me Anything” Panel from Nasdaq MarketSite on the Future of AI Infrastructure

Written by Customer Service on October 16, 2026. Posted in Public Companies.

“The Trillion Dollar AI Bottleneck” to feature Fabric.AI Senior Strategic Advisor James Altucher in a discussion of the technologies needed to support AI’s continued growth NEW YORK, NY, Oct. 16, 2026 (GLOBE NEWSWIRE) — Fabric.AI (Nasdaq: FABC) (“Fabric.AI” or the “Company”), an AI infrastructure company developing a suite of fabless semiconductor technologies for next-generation AI factories, today announced that James Altucher, Fabric.AI’s Senior Strategic Advisor, will join Michael Murray, Chief Executive Officer, President and Chairperson of its development partner Kopin Corporation (Nasdaq: KOPN), and AI expert Cortney Harding for a live YouTube “Ask Me Anything” panel. Hosted by Kopin and titled “The Trillion Dollar AI Bottleneck,” the event will stream live from Nasdaq MarketSite in New York City on October 20, 2026, at 11:00...

Liberty Defense Announces New Board Member

Written by Customer Service on October 16, 2026. Posted in Public Companies.

Adding An Experienced Government and Commercial Security Leader WILMINGTON, Mass., Oct. 16, 2026 (GLOBE NEWSWIRE) — Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (NASDAQ: DETX), a leading technology provider of AI-based next generation detection solutions for concealed weapons and threats, today announced the appointment of Steve Karoly to the Board of Directors, effective immediately. Steve will replace outgoing CEO Bill Frain, who is leaving the company at the end of October, on the Board. “We are extremely pleased to welcome Steve to the Board of Directors,” said John Percival, Chairman of Liberty Defense. “Steve has strong experience in government and transportation security from his years at TSA, Customs & Border Protection and K2 Security Screening. He brings valuable insights into federal...

Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual Meeting

Written by Customer Service on October 16, 2026. Posted in Public Companies.

ACCLARENT AERA® Eustachian Tube TreatmentSimulation of a minimally invasive ear procedure using the ACCLARENT AERA® Eustachian Tube Treatment.PRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) — Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, taking place October 17-20 in Los Angeles, California. At this year’s meeting, Integra will showcase its growing portfolio of ENT technologies and instruments, including the ACCLARENT AERA® Eustachian Tube Treatment, TruDi® Navigation System, MicroFrance® ENT and Laparoscopy Instruments, Bien-Air® Drill and Shaver Systems and RELIEVA SPINPLUS® Balloon Sinuplasty System. Additionally,...

Propanc Biopharma’s Lead Asset PRP Reprograms Chemotherapy-Resistant Pancreatic Cancer Cells

Written by Customer Service on October 16, 2026. Posted in Public Companies.

New Preclinical Findings Identify Potential Strategy to Remodel Resistant Tumor State & Restore Therapeutic Vulnerability MELBOURNE, Australia, Oct. 16, 2026 (GLOBE NEWSWIRE) — Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company focused on developing novel treatments for chronic diseases including recurrent and metastatic cancer, today announced new preclinical research from an academic–industry collaboration from the Universities of Jaén and Granada, led by Dr. Maria Belén Toledo, has identified pancreatic proenzyme formulation, PRP, as a potential strategy for addressing chemotherapy resistance in pancreatic cancer. Chemotherapy-resistant tumor cells can acquire adaptive cellular states that allow them to survive treatment and maintain aggressive characteristics. The study investigated...

Private Bancorp of America, Inc. Announces Strong Net Income for Third Quarter 2026

Written by Customer Service on October 16, 2026. Posted in Earnings Releases And Operating Results.

Third Quarter 2026 HighlightsNet income for the third quarter of 2026 was $11.4 million, compared to $13.1 million in the prior quarter and $9.7 million in the third quarter of 2025. Net income for the third quarter of 2026 represents a return on average assets of 1.65% and a return on average tangible common equity(1) of 15.62%. Diluted earnings per share for the third quarter of 2026 was $1.97, compared to $2.27 in the prior quarter and $1.65 in the third quarter of 2025. Core deposits were $2.36 billion as of September 30, 2026, an increase of $31.8 million, or 1.4%, from June 30, 2026, and an increase of $171.5 million, or 7.8%, from September 30, 2025. Total deposits were $2.41 billion. There was no change to the balance in brokered deposits. Total cost of deposits was 1.66% for the third quarter of 2026, compared to 1.63% in the...

Aduro Clean Technologies Reports First Quarter Fiscal Year 2027 Results and Provides Business Update

Written by Customer Service on October 16, 2026. Posted in Earnings Releases And Operating Results.

LONDON, Ontario, Oct. 16, 2026 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (TSX: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, has filed its interim condensed consolidated financial results for the three months ended August 31, 2026, and is pleased to provide the following highlights. Unless otherwise indicated, all financial information in this press release is reported in Canadian dollars. “During the first quarter of fiscal 2027, Aduro continued to advance and build on its progress at both the NGP Pilot Plant and across other areas, including engineering, feedstock, and commercial activities necessary for industrial deployment,”...

Royalty Pharma declares fourth quarter 2026 dividend

Written by Customer Service on October 16, 2026. Posted in Dividend Reports And Estimates.

NEW YORK, Oct. 16, 2026 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2026 of $0.235 per Class A ordinary share. The dividend will be paid on December 10, 2026, to shareholders of record at the close of business on November 13, 2026. About Royalty Pharma plc Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Biomerica Reports First Quarter Fiscal 2027 Financial Results

Written by Customer Service on October 16, 2026. Posted in Earnings Releases And Operating Results.

InFoods® IBS Commercial Progress: Medicare-related test orders increased 120% in September 2026 compared to August, with growing physician participation and repeat ordering activityInFoods® IBS update: 100% of all initial valid Medicare claims processed as of October 15, 2026 have been paid at the full CMS payment rate of $300Engaged B. Riley Securities, Inc. to support the Board’s ongoing evaluation of potential strategic opportunities, including partnerships and business combinationsTotal operating expenses decreased approximately 14% year over yearOver-the-counter sales increased approximately 81% compared to the first quarter of fiscal 2026Cash and cash equivalents more than doubled to approximately $2.7 million at August 31, 2026, from approximately $1.3 million at May 31, 2026IRVINE, Calif., Oct. 16, 2026 (GLOBE...

Author: Customer Service

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals